Publications by authors named "C Bernigaud"

Claim this Profile
P
Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.
Gilles Tiraboschi, Kim Papp, Thomas Bieber, Stephan Weidinger, Lisa Beck, Charlotte Bernigaud

CPT Pharmacometrics Syst Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study.
Adam Reich, Andrew Blauvelt, Stephan Weidinger, Vivian Y Shi, Norito Katoh, Charlotte Bernigaud

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study.
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, Adam Reich, Chih-Hung Lee, Charlotte Bernigaud

Immunotherapy· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycobacterium chelonae cutaneous infections unrelated to invasive procedures: A multicentre retrospective case series.
Alicia Leymarie, Pascal Thibon, Charlotte Bernigaud, Claire Daurel, Elise Ouedraogo

J Eur Acad Dermatol Venereol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, Adam Reich, Chih-Hung Lee, Charlotte Bernigaud

J Allergy Clin Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis